Malaria cost-effectiveness of therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m Changes made per Mahshid's request |
||
(One intermediate revision by one other user not shown) | |||
Line 2: | Line 2: | ||
{{Malaria}} | {{Malaria}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
Line 17: | Line 15: | ||
[[Category:Tropical disease]] | [[Category:Tropical disease]] | ||
[[Category:Deaths from malaria]] | [[Category:Deaths from malaria]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} |
Latest revision as of 18:00, 18 September 2017
Malaria Microchapters |
Diagnosis |
---|
Treatment |
Case studies |
Malaria cost-effectiveness of therapy On the Web |
American Roentgen Ray Society Images of Malaria cost-effectiveness of therapy |
Risk calculators and risk factors for Malaria cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Although effective anti-malarial drugs are on the market, the disease remains a threat to people living in endemic areas who have no proper and prompt access to effective drugs. Access to pharmacies and health facilities, as well as drug costs, are major obstacles. Médecins Sans Frontières estimates that the cost of treating a malaria-infected person in an endemic country was between US$0.25 and $2.40 per dose in 2002.[1]
References
- ↑ Medecins Sans Frontieres, "What is the Cost and Who Will Pay?"